SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will hold a conference call to discuss business progress and updates.
丹佛，2024年12月04日（環球新聞）-- SeaStar醫療控股公司（納斯達克：ICU），一家處於商業階段的醫療器械公司，正在開發專有解決方案以減少超炎症對重要器官的影響，管理層宣佈將舉行一次電話會議，討論業務進展和更新。
| Date/Time: | Wednesday, December 11, 4:30 p.m. ET / 1:30 p.m. PT |
| Pre-Registration: | Participants can pre-register for the conference call here: |
| Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. | |
| Dial In: | Those who choose not to pre-register can access the live conference call by dialing the following and requesting the SeaStar Medical call: |
| 866-777-2509 within the U.S. | |
| 412-317-5413 from outside the U.S. |
| 日期/時間： | 2023年12月11日，下午4:30 ET / 下午1:30 PT |
| 預註冊： | 參與者可以在這裏預註冊電話會議： |
| 預先註冊的來電者將獲得會議通行碼和唯一的PIN碼，以便立即訪問電話並繞過實時運營商-5G。參與者可以在任何時間進行預註冊，包括在電話開始時間之前和之後。 | |
| 撥打： | 選擇不提前註冊的人可以撥打以下電話以訪問實時會議電話，並請求SeaStar Medical的電話： |
| 在美國撥打866-777-2509。 | |
| 從美國以外撥打412-317-5413。 |
The live webcast of the conference call also will be available here. A replay of the call will be available for 48 hours beginning two hours after its completion by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 3855739. The webcast will also be archived here.
會議電話的直播網絡廣播將在此處提供。電話重播將在會議結束後兩小時內提供，爲期48小時，撥打877-344-7529（美國境內），855-669-9658（加拿大）或412-317-0088（美國境外），並輸入會議ID 3855739。此處也將存檔網絡廣播。
About SeaStar Medical
SeaStar Medical is a commercial-stage medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical's novel technologies rely on science and innovation to provide life-saving solutions to critically ill patients. The Company is developing and commercializing cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. For more information visit or visit us on LinkedIn or X.
關於SeaStar Medical
SeaStar Medical是一家商業階段的醫療科技公司，正在重新定義體外治療如何減少過度炎症對重要器官的影響。SeaStar Medical的創新技術依賴於科學和創新，爲危重病患者提供救命解決方案。公司正在開發和商業化以細胞爲導向的體外療法，針對導致全身炎症的效應細胞，這些細胞會造成直接的組織損傷，並分泌一系列促炎症細胞因子，啓動並傳播失衡的免疫反應。欲了解更多信息，請訪問或在LinkedIn或X上關注我們。
Contact:
聯繫：
Alliance Advisors IR
Jody Cain
(310) 691-7100
Jcain@allianceadvisors.com
聯盟顧問投資者關係
喬迪·凱恩
(310) 691-7100
Jcain@allianceadvisors.com
# # #
# # #
譯文內容由第三人軟體翻譯。
